Skip to main content
SpringerLink
Log in

Does Change over Time in Delusional Beliefs as Measured with PDI Predict Change over Time in Belief Flexibility Measured with MADS?

  • Original Paper
  • Published:
Psychiatric Quarterly Aims and scope Submit manuscript

Abstract

Delusional beliefs and their behavioral consequences are predominant symptoms in patients with psychosis and play an important role in the treatment. Delusional beliefs are a multidimensional concept which can be divided into three components: distress, preoccupation and conviction of delusions. These can be measured using Peters delusions inventory (PDI-21). We question, whether changes in delusional beliefs over time during treatment measured with the PDI-21 can predict changes in belief flexibility measured with the Maudsley assessment of delusions schedule (MADS). We used a group of patients from a randomized controlled trial for a cognitive intervention for psychosis or psychotic symptoms. Aside standard treatment for psychosis, half of the patients took part in a group treatment “Michael’s game”. Patients were assessed at baseline (T1), at 3 months (T2), and at 9 months (T3). We measured delusional beliefs using PDI-21 and belief flexibility with the MADS. One hundred seventy-two patients were included in the analysis. We measured a main effect of PDI-21scores on belief flexibility measured with MADS. PDI-21 Conviction scores predicted outcomes for all measured MADS items. Increasing PDI Distress and Preoccupation scores were predictors for being more likely to dismiss beliefs and change conviction. Time itself was a predictor for changing conviction and being able to plan a behavioral experiment. Overall the changes in PDI scores predicted outcomes for belief flexibility measured with MADS items. The PDI-21 could be a simple and effective way to measure progress in treatment on delusional beliefs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005;353(12):1209–23.

    Article  CAS  Google Scholar 

  2. Lally J, MacCabe JH. Antipsychotic medication in schizophrenia: a review. Br Med Bull. 2015;114(1):169–79.

    Article  CAS  Google Scholar 

  3. Garety PA, Freeman D, Jolley S, Dunn G, Bebbington PE, Fowler DG, et al. Reasoning, emotions, and delusional conviction in psychosis. J Abnorm Psychol. 2005;114(3):373–84.

    Article  Google Scholar 

  4. Ward T, Garety PA. Fast and slow thinking in distressing delusions: a review of the literature and implications for targeted therapy. Schizophr Res. 2019;203:80–7.

    Article  Google Scholar 

  5. Wessely S, Buchanan A, Reed A, Cutting J, Everitt B, Garety P, et al. Acting on delusions. I: prevalence. Br J Psychiatry. 1993;163(01):69–76.

    Article  CAS  Google Scholar 

  6. Zhu C, Sun X, So SH. Associations between belief inflexibility and dimensions of delusions: a meta-analytic review of two approaches to assessing belief flexibility. Br J Clin Psychol. 2018;57(1):59–81.

    Article  Google Scholar 

  7. Brabban A, Tai S, Turkington D. Predictors of outcome in brief cognitive behavior therapy for schizophrenia. Schizophr Bull. 2009;35(5):859–64.

    Article  Google Scholar 

  8. Verdoux H, Maurice-Tison S, Gay B, Os JV, Salamon R, Bourgeois ML. A survey of delusional ideation in primary-care patients. Psychol Med. 1998;28(1):127–34.

    Article  CAS  Google Scholar 

  9. So SH, Peters ER, Swendsen J, Garety PA, Kapur S. Changes in delusions in the early phase of antipsychotic treatment – an experience sampling study. Psychiatry Res. 2014;215(3):568–73.

    Article  Google Scholar 

  10. Mehl S, Werner D, Lincoln TM. Does cognitive behavior therapy for psychosis (CBTp) show a sustainable effect on delusions? A meta-analysis. Front Psychol [Internet]. 2015[cited 2019 Apr 24];6. Available from: http://journal.frontiersin.org/Article/10.3389/fpsyg.2015.01450/abstract.

  11. Lincoln TM, Rief W, Westermann S, Ziegler M, Kesting M-L, Heibach E, et al. Who stays, who benefits? Predicting dropout and change in cognitive behaviour therapy for psychosis. Psychiatry Res. 2014;216(2):198–205.

    Article  Google Scholar 

  12. Khazaal Y, Chatton A, Dieben K, Huguelet P, Boucherie M, Monney G, et al. Reducing delusional conviction through a cognitive-based group training game: a multicentre randomized controlled trial. Front Psych [Internet]. 2015 [cited 2019 Apr 24];6. Available from: http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00066/abstract.

  13. Khazaal Y, Favrod J, Azoulay S, Finot SC, Bernabotto M, Raffard S, et al. “Michael’s game,” a card game for the treatment of psychotic symptoms. Patient Educ Couns. 2011;83(2):210–6.

    Article  Google Scholar 

  14. Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry. 2003;64(6):663–7.

    Article  CAS  Google Scholar 

  15. Shafer A. Meta-analysis of the brief psychiatric rating scale factor structure. Psychol Assess. 2005;17(3):324–35.

    Article  Google Scholar 

  16. Pichot P, Samuel-Lajeunesse B, Lebreaux AM. A new experimenatl form of BPRS. Ann Med Psychol (Paris). 1973;2(2):254–63.

    CAS  Google Scholar 

  17. Sullivan Pepe M, Anderson GL. A cautionary note on inference for marginal regression models with longitudinal data and general correlated response data. Commun Stat - Simul Comput. 1994;23(4):939–51.

    Article  Google Scholar 

  18. Peters E, Joseph S, Day S, Garety P. Measuring delusional ideation: the 21-item Peters et al. delusions inventory (PDI). Schizophr Bull. 2004;30(4):1005–22.

    Article  Google Scholar 

Download references

Acknowledgements

We thank the participants and the game leaders, as well as Karen Dieben, Gregoire Monney, Virginie Salamin, Dr. Fethi Bretel, Silke Azoulay, Elodie Pesenti, Raoul Krychowski, Andreia Costa Prata, Dr. Alexei Traian, Dr. Thomas Charpeaud, Prof. Daniele Zullino, Prof. Alberto Parabiaghi, Joanne Corpataux, Milena Kriz, Dr. Giacomini, Claude Hayoz (Fondation HorizonSud), Dr. Georges Klein, Phillippe Laffond, Prof. Eric Bonvin, Prof. Sonia Dollfus, Prof. Thierry D’Amato, Prof. Jean-Michel Llorca, Dr. George Berthon, Dr. Céline Plassereaud, Dr. Véronique Roure, Natacha Boureykoff, Marie-Josée Durak, Dr. Maria Teresa Caldera, Dr. Roberta Bossoletti, and Dario Caffaro. Funding: Swiss National Science Foundation Grant 32003B-121038.

Author information

Authors and Affiliations

  1. Geneva University Hospitals, Ch, du Petit Bel-Air 2, 1225, Chêne-Bourg, Switzerland

    Louise Penzenstadler, Anne Chatton, Philippe Huguelet & Javier Bartolomei

  2. Faculty of Medicine, Geneva University, Geneva, Switzerland

    Anne Chatton & Philippe Huguelet

  3. UNICAEN, Imagerie et Strategies Therapeutiques de la schizophrenie (ISTS), Normandie University, EA4766, 14000, Caen, France

    Laurent Lecardeur & Perrine Brazo

  4. UNICAEN, CHU de Caen Normandie, Service de Psychiatrie d’adultes, Centre Esquirol, Normandie University, 14000, Caen, France

    Perrine Brazo

  5. Unité Mobile de Psychiatrie, Centre Hospitalier Princesse Grace, Monaco, Monaco

    Elodie Murys

  6. Laboratoire Clinique Psychopathologique et Interculturelle, Université de Toulouse, Toulouse, France

    Florent Poupart

  7. Centre Hospitalo-Universitaire de Toulouse, Toulouse, France

    Florent Poupart

  8. CRESOP, Centre Hospitalier le Vinatier, Bron, France

    Serge Rouvière

  9. PsyR2, INSERM U1028, CNRS UMR5292, PSYR2 Team, Lyon Neuroscience Research Center, Lyon, France Department of Consultation-Liaison Psychiatry, Université Claude Bernard Lyon 1, Lyon, France

    Mohamed Saoud

  10. La Source, School of Nursing Sciences, HES-SO University of Applied Sciences and Arts of Western Switzerland, Lausanne, Switzerland

    Jérôme Favrod

  11. Addiction Medicine, Department of Psychiatry, Lausanne University Hospitals, Lausanne, Switzerland

    Yasser Khazaal

  12. Research Center, Montreal University Institute of Mental Health, Montreal, Canada

    Yasser Khazaal

Authors
  1. Louise Penzenstadler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne Chatton
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Philippe Huguelet
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Laurent Lecardeur
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Javier Bartolomei
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Perrine Brazo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Elodie Murys
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Florent Poupart
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Serge Rouvière
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Mohamed Saoud
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Jérôme Favrod
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yasser Khazaal
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design of the original study. Louise Penzenstadler and Yasser Khazaal contributed to the conception and design of the secondary analysis. The formal analysis was performed by Anne Chatton. The first draft of the manuscript was written by Louise Penzenstadler, Jérôme Favrod and Yasser Khazaal and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Louise Penzenstadler.

Ethics declarations

Disclosure of Potential Conflicts of Interest

This study was funded by Swiss National Science Foundation Grant 32003B-121038. Yasser Khazaal and Jérôme Favrod are the authors of the game. The other co-authors declare that the research was conducted in the absence of any commercial or financial relationships that could be conceived as a potential conflict of interest.

Research Involving Human Participants and/or Animals

All procedures performed in studies involving human participants were in accordance with the ethical standards of the national research committees. The ethical committees of all four countries approved the trial. The protocol was registered (International Standard Randomized Controlled Trial Number Register: ISRCTN37178153) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.”

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Penzenstadler, L., Chatton, A., Huguelet, P. et al. Does Change over Time in Delusional Beliefs as Measured with PDI Predict Change over Time in Belief Flexibility Measured with MADS?. Psychiatr Q 90, 693–702 (2019). https://doi.org/10.1007/s11126-019-09659-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11126-019-09659-8

Keywords

Search

Navigation